| Literature DB >> 29092972 |
Karina V Grooteman1, Erwin J M van Geenen1, Joost P H Drenth1.
Abstract
A small proportion of gastrointestinal angiodysplasia bleeding leads to chronic blood cell transfusion dependency. There are no guidelines supporting decision-making among various treatments in patients with gastrointestinal angiodysplasia bleeding. When endoscopic argon plasma coagulation is ineffective, the angiogenesis inhibitors thalidomide and octreotide can be considered. We describe a 77-year-old woman who had side effects of these angiogenesis inhibitors, which caused her to have continued bleeding. She was successfully treated with tranexamic acid with a substantial decrease in need for red blood cell transfusions. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: Drugs: Gastrointestinal System; Gi Bleeding; Haematology (incl Blood Transfusion); Pharmacology And Therapeutics; Small Intestine
Mesh:
Substances:
Year: 2017 PMID: 29092972 PMCID: PMC5695428 DOI: 10.1136/bcr-2017-221832
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X